Benzarone
-
Benzarone
structure -
-
CAS No:
1477-19-6
-
Formula:
C17H14O3
-
Chemical Name:
Benzarone
-
Synonyms:
Methanone,(2-ethyl-3-benzofuranyl)(4-hydroxyphenyl)-;Ketone,2-ethyl-3-benzofuranyl p-hydroxyphenyl;(2-Ethyl-3-benzofuranyl)(4-hydroxyphenyl)methanone;Benzarone;2-Ethyl-3-benzofuranyl p-hydroxyphenyl ketone;2-Ethyl-3-(p-hydroxybenzoyl)benzofuran;2-Ethyl-3-(4-hydroxybenzoyl)benzofuran;2-Ethyl-4′-hydroxy-3-benzoylbenzofuran;Fragivix;L 2197;Fragivil;Benzaron;Fagivil;L 2179-Labaz;NSC 82134;(2-Ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone;(2-Ethyl-1-benzofuran-3-yl)-(4-hydroxyphenyl)methanone
- Categories:
-
CAS No:
Description
Pale Yellow Solid
Benzarone is a member of 1-benzofurans.|Benzbromarone is a nonpurine xanthine oxidase inhibitor used for the treatment of gout, but never approved for use in the United States because of concerns over reports of acute liver injury and deaths with its use.
Characteristics
50.4
4.3
1.1601 (rough estimate)
124.3 °C
369.5°C (rough estimate)
240.2ºC
1.5490 (estimate)
1.36E-09mmHg at 25°C
Peritoneal-mouse LD50: 200 mg/kg
Flammable; burning produces irritating fumes
Safety Information
Ventilated, low temperature and dry; stored separately from food materials in warehouse
P201, P202, P273, P281, P308+P313, P391, P405, P501
H361
|Warning|H361 (80%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]|P201, P202, P273, P281, P308+P313, P391, P405, and P501|Aggregated GHS information provided by 6 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Toxicity
highly toxic
Liver test abnormalities have been reported to occur rarely during benzbromarone therapy, in only 0.1% of patients in clinical trials. Furthermore, it was used widely for many years without reports of hepatotoxicity until the late 1980s, after which several cases of acute liver injury and acute liver failure during benzbromarone therapy were published. Hepatic injury arises after 1 to 6 months of therapy presenting with jaundice and fatigue, usually with a hepatocellular pattern of enzyme elevations. Immunoallergic symptoms (rash, fever) are uncommon. Low levels of autoantibodies have been reported in some cases with liver histology demonstrating chronic active hepatitis, particularly if benzbromarone is not stopped promptly. Upon stopping therapy, resolution is typically within 1 to 3 months. The hepatic injury from benzbromarone is similar to that reported with benzarone, a structurally related drug that was used for peripheral vascular disease, but also withdrawn also because of concerns over hepatotoxicity.
Drug Information
Benzbromarone is a nonpurine xanthine oxidase inhibitor used for the treatment of gout, but never approved for use in the United States because of concerns over reports of acute liver injury and deaths with its use.
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)
benzaron
Benzarone Use and Manufacturing
In a RBF/SB (50 mL), benzofuran (12; 1.00 g; 3.57 mmol) was diluted with DMF (18 mL) and NaSEt (455 mg) was added. The mixture was heated (125-130 °C; 1.0 h). Next, the mixture was quenched (2 vol NH4CI aq) and extracted with EtOAc (4 x 75 mL). The organic phase was washed with HEthanethiol (8 mL) was added dropwise to a suspension of sodium hydride (640 mg, 16.0 mmol) in dry THF (15 mL) under ice-water bath. Stir for 5 minutes. A large number of solid precipitation. The solvent was distilled off under reduced pressure. DMF (20 mL) was then added to the residue. The reaction solution A was obtained. A solution of compound 2 (3.0 g, 10.7 mmol) in DMF (20 mL) was added dropwise to reaction solution A. Followed by stirring at 110°C for 3 hours. Cooled to room temperature. Water (120 mL) was added. Extraction with ethyl acetate (60 mL x 3). The combined organic phases were washed with saturated brine (30 mL x 2). Dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure. The product was purified by column chromatography (200-300 mesh silica gel, ethyl acetate: petroleum ether = 1:50 to 1: 6) to obtain (2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone (3) (2.2 g). The yield was 77.2percent.(1) To a 500 mL reaction vessel, 112 g of chloroform, 36 g of 2-ethylbenzofuran, and 72 g of p-methoxybenzoyl chloride were added, and then a feed tube was washed by further adding 50 g of chloroform. When cooling to 10-30 ° C, then the first addition of Lewis acid 17g; cooling to the last temperature range for the second time plus Lewis acid 17g; cooling to the last temperature range for the third time to add Lewis acid 17g, a total of 51g of Lewis acid was added, and the temperature was kept constant at 15-30 ° C for 4 h;(2) After the completion of the heat preservation reaction, tap water is quenched; acidified with 110 g of dilute hydrochloric acid (10percent).Then, the heating is started to 65-70 ° C, and the stirring is kept for 0.5 hour; the stirring is stopped for 0.5 hours, and then the liquid is separated, and the material in the reactor is washed twice with hot water of about 70 ° C.The washed material is sucked into the reactor for distillation under reduced pressure; after the distillation is completed, it is slightly lowered.The temperature was about 65 ° C, and 35 g of methanol was further added thereto, and the mixture was cooled, cooled, and crystallized by freezing, filtered, and dried to obtain 60 g of a benzalkonone intermediate (white solid).(3) Add 140g of chloroform, benzalkonone intermediate dry product 60g, add 30g of chloroform rinse feed pipe to the clean 500ml reactor; pass the cooling water to reduce the temperature inside the reactor, when the temperature is stable at 15-30 At a temperature of °C, 43g of Lewis acid was added at a time, and stirred under the action of cooling water for 0.5 hours; after the completion of the stirring, the temperature was raised to 90-95 ° C, and the heat preservation was started.Should be 2-3h; after the reaction is completed, pass the cooling water and start to cool down to 20-30 °C;(4) After cooling for 3 hours, add water to quench; add 130 g of dilute hydrochloric acid (10percent) to acidify, stir for half an hour, then warm to 90-95 ° C, stir for half an hour to separate the liquid; after the liquid separation, use 70 ° C or so Washed twice, will wash the finished materialDistillation was carried out, acetonitrile and petroleum ether were added to cool and crystallize, and after filtration, it was rinsed with an appropriate amount of solvent to obtain a crude benzalkonium. Then, 40 g of the obtained benzalkonone crude product and 70 g of acetonitrile and petroleum ether were charged into the reactor, activated carbon was added, and the temperature was immediately maintained by heating and refluxing for 0.5 hour.It was filtered with a precision filter under air pressure, cooled, crystallized, filtered, and dried to obtain 35 g of benzalkonone, and the yield of the final product was 68.2percent.(b) Complexes of aluminium chloride with 2-ethyl-3-(4-methoxy- and 4-hydroxybenzoyl)benzofurans Into a first reactor, 280.3 g (1 mol) of crystallized 2-ethyl-3-(4-methoxybenzoyl)benzofuran and 588 g of toluene were introduced. The solid was dissolved by heating, with stirring, the reactants were dried azeotropically and the solution obtained was cooled to 10° C. Into a second perfectly dry reactor, 253 g of anhydrous toluene were introduced followed, with cooling, by 241 g (1.8 mol) of anhydrous aluminium chloride. The temperature of the mass was adjusted to 0°+- 5° C. and the toluene solution of 2-ethyl-3-(4-methoxybezoyl)benzofuran prepared in the first reactor was added. The addition took approximately 90 minutes, with external cooling so as not to exceed 15° C. The solution produced in this manner, containing the 1:1 complex of aluminium chloride with 2-ethyl-3-(4-methoxybenzoyl)benzofuran was then kept at a temperature below or equal to 15° C. Into the first reactor 356 g of anhydrous toluene were introduced and then stirred and placed under a residual pressure of 300-350 mm Hg, before the toluene was heated to reflux (mass temperature:84°+- 1° C.). The vacuum and the temperature were stabilized, the system was set for distillation and then a gradual addition of the solution in the second reactor, containing the complex, was started (total addition time of complex:4 to 5 h; toluene-containing distillate:about 1400 g). The second reactor was rinsed with 48 g of anhydrous toluene and the mass was heated to 100° C. while the reduced pressure in the reactor was gradually lowered (toluene-containing distillate: approximately 105 g), which provoked the formation of the 2:1 complex of aluminium chloride with 2-ethyl-3-(4-hydroxybenzoyl)benzofuran. In this manner, a toluene solution of a molecular complex of aluminium chloride with 2-ethyl-3-(4-hydroxybenzoyl)benzofuran was obtained.In this manner, 233 g of crude 2-ethyl-3-(4-hydroxybenzoyl) benzofuran, or benzarone, were obtained. Yield:83+- 3percent [based on 2-ethyl-3-(4-methoxybenzoyl)benzofuran].(1) To a 500 mL reaction vessel, 112 g of chloroform, 36 g of 2-ethylbenzofuran, and 72 g of p-methoxybenzoyl chloride were added, and then a feed tube was washed by further adding 50 g of chloroform. When cooling to 10-30 ° C, then the first addition of Lewis acid 17g; cooling to the last temperature range for the second time plus Lewis acid 17g; cooling to the last temperature range for the third time to add Lewis acid 17g, a total of 51g of Lewis acid was added, and the temperature was kept constant at 15-30 ° C for 4 h;(2) After the completion of the heat preservation reaction, tap water is quenched; acidified with 110 g of dilute hydrochloric acid (10percent).Then, the heating is started to 65-70 ° C, and the stirring is kept for 0.5 hour; the stirring is stopped for 0.5 hours, and then the liquid is separated, and the material in the reactor is washed twice with hot water of about 70 ° C.The washed material is sucked into the reactor for distillation under reduced pressure; after the distillation is completed, it is slightly lowered.The temperature was about 65 ° C, and 35 g of methanol was further added thereto, and the mixture was cooled, cooled, and crystallized by freezing, filtered, and dried to obtain 60 g of a
Benzarone is an EYA (Eyes Absents), multifunctional protein involved in organogenesis, inhibitor which makes it a potent anticancer agent. EYA~"s are over expressed in ovarian and breast cancers. As well it is involved in the synthesis of Human Uric Acid Transporter 1 inhibitors which may be used to treat kidney diseases.
Methanone, (2-ethyl-3-benzofuranyl)(4-hydroxyphenyl)-: INACTIVE
Computed Properties
Molecular Weight:266.29
XLogP3:4.3
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:3
Exact Mass:266.094294304
Monoisotopic Mass:266.094294304
Topological Polar Surface Area:50.4
Heavy Atom Count:20
Complexity:346
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Benzarone
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
InquiryUnit Price: $7000-8000 /MT FOBCAS No.: 1477-19-6Grade: Cosmetics GradeContent: 99%
-
CN
6 YRS
Business licensedDistributor Supplier of 4-ISOPROPYL-3-METHYLPHENOL,4-Hydroxy-3-methoxyacetophenone,Benzarone,Sodium picosulfate
Latest News on Benzarone
- The world's first uniform international safety standard for plastics and rubber
- The nation's first group standard for meltblown cloth for masks is released
- Several compulsory national standards have been issued
- Japan has seized the right to formulate international standards
- Henan Efforts to Improve the Standardized Management Level of Food Production
Learn More Other Chemicals
-
Fluocinolone
807-38-5
-
2-Propenoic acid, 2-methyl-, methyl ester, polymer with butyl 2-propenoate, 2-ethylhexyl 2-propenoate and 2-propenoic acid
42398-14-1
-
(3S,7R)-N-[(2-fluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide
1863916-87-3
-
1,1-Cyclopropanedicarboxylic acid, 1,1-dimethyl ester Formula
6914-71-2
-
(6R,7R)-7-[[2-amino-2-(cyclohexen-1-yl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Formula
37051-00-6
-
3-Hydroxy-4-Methyl-2(5H)-thiophenone Formula
34876-35-2
-
10-Methoxy-5H-dibenz[b,f]azepine-5-carbonyl chloride Structure
28721-08-6
-
3,7-Dihydro-3,7-dimethyl-1-(2-propen-1-yl)-1H-purine-2,6-dione Structure
2530-99-6
-
What is 1-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-7-hydroxy-3,4-dihydrocarbostyril
1797983-65-3
-
What is 3,5-DIIODO-4'-(4-HYDROXYPHENOXY)BENZOICACID
2055-97-2